The Latest Breaking News from NYSE

Will Palantir, Pfizer And Oracle Stocks Continue Higher In This Trend?

Oracle Corporation (NYSE: ORCL), Pfizer Inc (NYSE: PFE) and Palantir Technologies Inc (NYSE: PLTR) were all trading near to fla

Benzinga · Jun 30, 2022

What Are Whales Doing With UnitedHealth Group

Someone with a lot of money to spend has taken a bearish stance on UnitedHealth Group (NYSE:UNH). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jun 30, 2022

Looking At Lowe's Companies's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Lowe's Companies. Looking at options history for Lowe's Companies (NYSE:LOW) we detected 11 strange trades.

Benzinga · Jun 30, 2022

Expert Ratings for Crown Castle Intl

Crown Castle Intl (NYSE:CCI) has observed the following analyst ratings within the last quarter:

Benzinga · Jun 30, 2022

Jefferies Maintains Hold Rating for Douglas Emmett: Here's What You Need To Know

Jefferies has decided to maintain its Hold rating of Douglas Emmett (NYSE:DEI) and lower its price target from $31.00 to $24.00. Shares of Douglas Emmett are trading down 1.04% over the last 24 hours, at $22.32 per share. A move to $24.00 would account for a 7.5% increase from the…

Benzinga · Jun 30, 2022

EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform

Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors.

Benzinga · Jun 30, 2022

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session

 Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.

Benzinga · Jun 30, 2022

Tsakos Energy Navigation Clocks 8% Top-Line Growth In Q1

Tsakos Energy Navigation Ltd. (NYSE:TNP) reported a first-quarter FY22 Voyage revenue increase of 7.7% Y/Y to $149.7 million, below the consensus of $152.71 million. EPS loss narrowed to $(0.12) from $(0.80) in 1Q21, beating the consensus of $(0.21). The operating income increased to $9.57 million, from $2.22 million a year ago,…

Benzinga · Jun 30, 2022

Looking At Exxon Mobil's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Exxon Mobil (NYSE:XOM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jun 30, 2022

Why Aspen Aerogels Stock Spiked Today

Aspen Aerogels Inc (NYSE: ASPN) shares are trading higher Thursday after the company announced it decided not to proceed with the concurrent public offerings of its common stock and its green convertible senior notes due 2027 due to market conditions.

Benzinga · Jun 30, 2022